Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

November 1, 2015

Study Completion Date

November 1, 2015

Conditions
Pulmonary Hypertension
Interventions
DRUG

Macitentan

oral tablet, 10 mg once daily

DRUG

Placebo

matching placebo

Trial Locations (32)

1070

Hôpital Erasme, Cliniques Universitaires de Bruxelles, Cardiologie, Brussels

3000

University Hospital Gasthuisberg / Interne Geneeskunde - I.G. Pneumologie, Leuven

14004

Hospital Reina Sofia Servicio de Cardiologia, Córdoba

28041

Hospital Universitario 12 Octubre Servicio de Cardiología, Madrid

34149

Ospedali Riuniti Di Trieste, Trieste

34362

Carmel Medical Center, Pulmonary Unit, Haifa

40138

A.O. Universitaria Policlinico S. Orsola-Malpighi - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale - Unità Operativa di Cardiologia, Bologna

40202

Kentuckiana Pulmonary Associates, Louisville

48109

University of Michigan Internal Medicine Cardiology, Pulmonary Hypertension Program, Ann Arbor

52621

The Chaim Sheba Medical Center / The Institute of Pulmonology, Physiology and Exercise, Tel Litwinsky

76100

Kaplan Medical Centre / Pulmonary Institute and Department of Medicine, Rehovot

91120

Institute of Pulmonology Hadassah Medical Centre : Ein Karem, Jerusalem

02118

Boston University School of Medicine, Boston

Unknown

Washington University School of Medicine - Center for Advanced Med, St Louis

The Lindner Clinical Trial Center, Cincinnati

Houston Methodist Hospital - Heart Failure/Pulm Hypertension, Houston

Krankenhaus der Elisabethinen Linz, 2. Interne Abteilung, Linz

Vancouver General Hospital - The Lung, Vancouver

FN Brno-Bohunice, I. interní kardiologická klinika, Brno

FN Olomouc, 1. Interní klinika - kardiologická, Olomouc

IKEM (Institut klinické a experimentální medicíny, Institute for Clinical and Experimental Medicine), Prague

Lékařská fakulta a Všeobecná fakultní nemocnice v Praze, II. Interní klinika kardiologie a angiologie, Prague

Hôpital Charles Nicolle Service de Cardiologie, Rouen

DRK Klinken Berlin Kopenick Klinik für Innere Medizin Kardiologie, Berlin

Universitätsklinikum Köln Herzzentrum / Klinik III für Innere Medizin (Kardiologie, Pneumologie, Angiologie und Intensivmedizin), Cologne

Universitätsklinik Schleswig-Holstein Campus Kiel Klinik für Innere Medizin III Kardiologie und Angiologie, Kiel

Klinikum der Universität München Medizinische Klinik und Poliklinik 1 - Großhadern Schwerpunkt Pneumologie, Munich

Universitätsklinik für Kardiologie Schweizer Herz- und Gefässzentrum Bern, Bern

Centre Hospitalier Universitaire Vaudois Service de Cardiologie, Lausanne

A-1090

Medical University of Vienna and AKH Cardiology, Vienna

08035

Hospital Vall d´Hebron Servicio de Cardiologia, Barcelona

08036

Hospital Clinic Servicio de Cardiologia, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02070991 - Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction | Biotech Hunter | Biotech Hunter